Estradiol Patch, Gel, Cream or Pill: Which Form Is Right for You?
No single form of estradiol is best for everyone. Pills, patches, gels and vaginal creams differ in convenience, how they reach the bloodstream and some risks, and a licensed provider helps you choose based on your symptoms and history.
There is no single best form of estradiol. Tablets, skin patches, gels and low-dose vaginal creams all deliver the same hormone, but they differ in convenience, in how the estrogen reaches your bloodstream and in some risks, such as blood clots. A licensed provider helps you choose based on your symptoms, health history and daily routine, and many women switch forms over time.
Key takeaways
- Estradiol is the main estrogen made by the ovaries, and it is available as tablets, patches, gels and vaginal products.
- Estrogen absorbed through the skin bypasses the liver on its first pass, and large observational studies link it to a lower blood clot risk than pills.
- Low-dose vaginal estradiol treats vaginal and urinary symptoms with very little reaching the bloodstream.
- If you have a uterus, systemic estrogen is paired with a progestogen, such as progesterone, to protect the uterine lining.
- Cost, convenience and skin tolerance matter too, and quarterly supplies are often cheaper per month.
The forms side by side
| Form | How it is used | Good to know |
|---|---|---|
| Tablet | Swallowed once a day | Simple and inexpensive; passes through the liver first |
| Patch | Stuck on the lower belly or buttock, changed once or twice a week | Steady delivery; some people get skin irritation or patches that lift |
| Gel | Rubbed into the skin daily and left to dry | Flexible; avoid skin contact with others until dry |
| Vaginal cream | Applied inside the vagina | For dryness, painful sex and some urinary symptoms; very low absorption |
All of these are listed on our menopause hormone therapy page with monthly and quarterly prices.
Pills versus skin: the blood clot question
Estrogen taken by mouth passes through the liver before reaching the rest of the body. That first pass affects how the liver makes clotting proteins. Estrogen absorbed through the skin, from a patch or gel, largely avoids this effect.
A large 2019 study in the BMJ by Vinogradova and colleagues, using UK primary care records, found that oral hormone therapy was associated with a higher risk of venous blood clots, while transdermal estrogen was not associated with an increased risk in that analysis. The Menopause Society's 2022 position statement also notes that observational evidence favors non-oral routes for clot risk. These are observational findings, not a guarantee for any individual, but they are one reason providers often consider a patch or gel for women with risk factors such as higher body weight or a history of migraine.
Vaginal estradiol is different
Low-dose vaginal estradiol works mainly where it is applied. It is used for vaginal dryness, irritation, painful sex and some recurrent urinary symptoms that come with lower estrogen. Very little reaches the bloodstream at these low doses. When the FDA began updating hormone therapy labels in November 2025, The Menopause Society supported removing the boxed warning from low-dose vaginal estrogen for this reason.
Vaginal estradiol can be used alone or alongside systemic hormone therapy. It does not treat hot flashes.
Why progesterone is part of the plan
If you have a uterus, estrogen taken without a progestogen can thicken the uterine lining and raise the risk of endometrial cancer. Adding progesterone or a progestin protects the lining. That is why the boxed warning about endometrial cancer remains on systemic estrogen-alone products even after the 2025 to 2026 label changes, according to the HHS fact sheet. Women who have had a hysterectomy usually do not need a progestogen for this reason. Low-dose vaginal estradiol alone generally does not require one.
Micronized progesterone capsules are a common choice and are usually taken at bedtime, since some women find them mildly sedating.
Practical things that guide the choice
- Routine: a daily pill or gel versus a patch changed once or twice a week.
- Skin: some people react to patch adhesive; gels need a few minutes to dry.
- Other people at home: gels can transfer to partners, children or pets until dry.
- Health history: clot risk, migraine with aura, liver conditions and blood pressure all influence the route.
- Cost: on Golden Glow, quarterly supplies cost less per month than monthly plans. Our plan cost calculator compares them.
Frequently asked questions
Is a patch safer than a pill?
For blood clots, observational studies such as the 2019 BMJ analysis favor estrogen through the skin. Overall safety depends on your age, timing, health history and dose, which a licensed provider reviews.
Can I switch from pills to a patch later?
Yes. Many women change forms because of side effects, convenience or new health information. Your provider will adjust the plan and the dose.
Does vaginal estradiol carry the same risks as regular hormone therapy?
Low-dose vaginal estradiol acts mainly where it is applied, with very little absorbed, which is why The Menopause Society supported removing its boxed warning. Tell your provider about any history of breast cancer.
Do I need progesterone with every form?
If you have a uterus and use systemic estrogen (pill, patch or gel), a progestogen is usually needed to protect the uterine lining. Low-dose vaginal estradiol on its own generally does not require it.
Talk to a licensed provider
Choosing a form is a conversation, not a guess. Start an online menopause visit and a licensed provider will review your history and recommend the route and dose that fit you, if hormone therapy is appropriate. This article is educational and does not determine eligibility for any treatment.
Sources
- The 2022 hormone therapy position statement of The North American Menopause Society, Menopause (2022)
- Vinogradova et al., Use of hormone replacement therapy and risk of venous thromboembolism, BMJ (2019)
- The Menopause Society comments on the FDA announcement on hormone therapy (Nov 10, 2025)
- HHS fact sheet, FDA initiates removal of boxed warnings from menopausal hormone therapy products (Nov 10, 2025)
This article is educational and is not medical advice. Golden Glow content is written to be accurate and is reviewed against the sources above. Rx programs require an online visit with a licensed provider. Results vary.